+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Palatin Technologies Inc - logo

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.

Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • February 2017
  • 91 Pages
From
From
Ulcerative Colitis - Pipeline Review, H1 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2020

  • Drug Pipelines
  • April 2020
  • 671 Pages
From
From
Uveitis - Pipeline Review, H1 2020 - Product Thumbnail Image

Uveitis - Pipeline Review, H1 2020

  • Drug Pipelines
  • March 2020
  • 259 Pages
From
Uveitis Pipeline Analysis and Outlook, 2019 - Product Thumbnail Image

Uveitis Pipeline Analysis and Outlook, 2019

  • Report
  • May 2019
  • 140 Pages
From
Obesity - Pipeline Review, H2 2019 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 567 Pages
From
Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Insight, 2019 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
From
Erectile Dysfunction - Pipeline Insight, 2020 - Product Thumbnail Image

Erectile Dysfunction - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Global Sexual Dysfunction Drugs Market 2017-2021 - Product Thumbnail Image

Global Sexual Dysfunction Drugs Market 2017-2021

  • Report
  • August 2017
  • 91 Pages
From
From
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019 - Product Thumbnail Image

Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019

  • Drug Pipelines
  • September 2019
  • 60 Pages
From
From
From
Loading Indicator
adroll